Truist Financial
TFC
$47.07
+1.07%
Truist Financial Corporation is one of the three U.S. super-regional banks, formed by the 2019 merger of BB&T and SunTrust, operating a roughly $550 billion balance sheet across retail and commercial banking, cards, wealth management, investment banking, and point-of-sale lending, with a footprint concentrated in the mid-Atlantic and Southeast. It occupies a distinct position as a scale player in regional banking — large enough to compete nationally in commercial and capital markets services, yet more domestically and deposit-funded than the money-center giants. The current investor debate centers on whether Truist can convert a favorable regulatory backdrop and excess capital into durable net interest margin expansion and loan growth, while simultaneously executing an aggressive buyback program (roughly $1.2 billion repurchased in Q2 2026 alone) and paying a dividend yield near 4.8%. Sentiment has been dented by a string of analyst downgrades to Neutral/Equal Weight and a sharp summer-to-fall share-price slide, leaving the stock trading below book value and framing it as a value-versus-value-trap argument.…
TFC
Truist Financial
$47.07
Related headlines
Investment Opinion: Should I buy TFC Today?
Rating: Hold. Truist offers a 4.8% dividend yield and trades below book value, but flat revenue growth and a recent wave of analyst downgrades suggest limited near-term upside. The consensus Hold rating (mean 2.64) and average target of $54.03 (14.8% upside) reflect a balanced view: the stock is cheap, but catalysts are lacking.
Supporting evidence: TFC trades at 0.96x P/B and 9.48x forward PE, both at discounts to historical averages and the sector. Revenue growth is anemic at 0.75% YoY, but profitability is improving—net margin expanded to 20.4% from 16.4%, and operating margin rose to 23.85% from 20.03%. Free cash flow TTM is $5.797 billion, funding a 4.80% dividend yield (56.45% payout) and $1.2 billion in quarterly buybacks. The implied upside to the average analyst target is 14.8%, but the stock's negative relative strength (-17.30% YTD) and 3.93 short ratio indicate persistent selling pressure.
Risks and conditions: The biggest risks are continued revenue stagnation, further analyst downgrades, and credit deterioration. This Hold would upgrade to Buy if net interest margin expands and revenue growth turns positive (e.g., above 2% YoY), or if the stock price falls below $42 (near 52-week low) providing a better risk/reward. It would downgrade to Sell if revenue declines further or if credit costs spike. Valuation verdict: fairly valued to slightly undervalued relative to history, but the discount is justified by low ROE and flat growth; the stock is not a compelling buy until there is evidence of a fundamental turnaround.
Sign up to view all
TFC 12-Month Price Forecast
Truist is a cheaply valued regional bank with improving profitability but stagnant revenue and a cautious analyst community. The stock's 4.8% dividend yield and buybacks provide a floor, but without revenue growth, multiple expansion is unlikely. The risk/reward is balanced: downside to the 52-week low is about 11.6%, while upside to the average target is 14.8%. We would upgrade to bullish if revenue growth accelerates above 2% and net interest margin expands, or downgrade to bearish if credit costs rise or revenue declines further.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Truist Financial's 12-month outlook, with a consensus price target around $53.81 and implied upside of +14.3% versus the current price.
Average Target
$53.81
0 analysts
Implied Upside
+14.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$45 - $61
Analyst target range
Nineteen analysts cover Truist with a consensus recommendation of Hold (mean rating 2.64 on a 1–5 scale) and an average price target of $54.03, implying roughly +14.8% upside from the current $47.07. The consensus is neutral-to-cautious rather than bullish, and the recent ratings flow supports that: B of A Securities and UBS both downgraded to Neutral from Buy in July 2026, Morgan Stanley moved to Equal Weight from Overweight, and JP Morgan shifted to Underweight from Neutral — a clear pattern of fading sell-side enthusiasm even as the average target sits well above the market price.
The target range of $45.00 to $61.00 is wide (a 35.6% spread from low to high), signaling genuine disagreement about the path forward. The $61 high target likely assumes net interest margin expansion, accelerating loan growth, and multiple re-rating toward book value or above as buybacks shrink the share count; the $45 low target, just 4.4% below the current price, prices in continued margin compression, flat revenue, and credit normalization. With consensus 2027 EPS of $5.59 (range $4.91–$6.03) and revenue of $22.58 billion, the dispersion in estimates is moderate, but the downgrade trend and Hold consensus mean the stock lacks a near-term catalyst — investors should treat the +14.8% implied upside as contingent on execution rather than a base-case certainty.
Bulls vs Bears: TFC Investment Factors
The bear case currently has stronger near-term evidence: revenue is flat, analysts are downgrading, and the stock is in a clear downtrend with negative relative strength. However, the bull case rests on solid profitability improvement, a 4.8% dividend yield, and a valuation that already discounts stagnation. The single most important tension is whether net interest margin can expand enough to drive revenue growth—if it does, the stock could re-rate toward book value; if not, the value trap thesis prevails.
Bullish
- Deep discount to book and earnings: TFC trades at 0.96x price-to-book and 9.48x forward earnings, well below the sector and its own historical range (P/B 0.62–1.16x, PE 8.0–15.8x). The 25.6% discount between trailing and forward PE implies the market expects meaningful EPS growth, yet the stock is priced for stagnation.
- Profitability inflecting higher: Q2 2026 net income rose to $1.553 billion from $1.240 billion a year earlier, lifting net margin to 20.4% from 16.4% and gross margin to 64.0% from 59.6%. Operating margin expanded to 23.85% from 20.03%, demonstrating operating leverage even with flat revenue.
- Aggressive capital returns: Truist repurchased $1.2 billion of stock in Q2 2026 alone and pays a 4.80% dividend yield with a conservative 56.45% payout ratio. The $5.797 billion TTM free cash flow and $39.3 billion cash position comfortably fund these returns, shrinking share count and supporting EPS.
- Analyst targets imply upside: The $54.03 average price target represents 14.8% upside from $47.07, with a high target of $61.00 (29.6% upside). Despite recent downgrades, the consensus target remains well above the current price, suggesting the sell-side sees value at these levels.
Bearish
- Revenue stagnation: Q2 2026 revenue of $7.611 billion grew just 0.75% year over year, and the sequential trend shows revenue peaking at $7.844 billion in Q3 2025 before drifting lower. Flat net interest income and modest loan growth suggest the core franchise is not expanding.
- Analyst downgrade cycle: B of A Securities and UBS downgraded to Neutral from Buy in July 2026, Morgan Stanley moved to Equal Weight, and JP Morgan shifted to Underweight. This broad-based downgrade trend signals fading confidence in near-term catalysts.
- Weak relative performance: TFC has underperformed SPY by 17.30% YTD, 14.40% over six months, and 13.03% over three months, with a -21.47% max drawdown. The stock sits at only 37% of its 52-week range, indicating sellers remain in control.
- Low profitability versus peers: ROE of 8.14% and ROA of 1.06% are below typical regional bank benchmarks, reflecting the challenge of earning adequate returns on a $550 billion balance sheet. The 1.07 debt-to-equity ratio adds leverage risk in a credit downturn.
TFC Technical Analysis
Truist is in a corrective downtrend within a longer-term recovery: the stock is up 14.55% over the past year but has fallen 5.37% year-to-date and sits at $47.07, which is only about 37% of the way up its 52-week range of $41.60 to $56.20. That positioning — closer to the low than the high despite a positive 1-year return — indicates fading momentum rather than a breakout, and the -21.47% max drawdown confirms meaningful capital erosion from the highs. The stock is not yet at the 52-week low, but the drift lower suggests sellers remain in control and the burden of proof is on the bulls to defend the $46 area.
Short-term momentum is clearly decelerating and diverging from the longer-term trend: the stock is down 2.83% over one month and 10.34% over three months, versus a +14.55% one-year gain, a classic late-cycle rollover pattern. Relative strength is uniformly negative — -4.05% versus SPY over one month, -13.03% over three months, -14.40% over six months, and -17.30% YTD — meaning Truist is underperforming the market by a wide margin even as the S&P 500 has gained 11.93% YTD. The most recent session did show a +1.07% bounce to $47.07 from $46.57, but with a beta of 0.906 the stock offers only modest downside cushion and the bounce looks like stabilization rather than a trend reversal.
Key technical levels are well defined: support sits at the 52-week low of $41.60, roughly 11.6% below the current $47.07, while resistance is the 52-week high of $56.20, about 19.4% above. A decisive break below the $46 handle would likely open a test of the $41.60 low and signal that the value thesis is being rejected by the market; reclaiming the $50–$52 area (where the stock traded in August–September) would be the first evidence of a base. With beta at 0.906 — about 9% less volatile than SPY — position sizing can be somewhat larger than for high-beta names, but the negative relative strength and 3.93 short ratio (nearly four days of average volume sold short) mean the stock is vulnerable to further momentum-driven selling.
Beta
0.91
0.91x market volatility
Max Drawdown
-21.5%
Largest decline past year
52-Week Range
$43-$56
Price range past year
Annual Return
+14.6%
Cumulative gain past year
| Period | TFC Return | S&P 500 |
|---|---|---|
| 1m | -2.8% | +0.2% |
| 3m | -10.3% | +2.9% |
| 6m | -6.9% | +8.4% |
| 1y | +14.6% | +14.9% |
| ytd | -5.4% | +11.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
TFC Fundamental Analysis
Revenue is essentially flat rather than growing: Q2 2026 revenue of $7.611 billion rose just 0.75% year over year from $7.554 billion, and the multi-quarter trend is stagnant — $7.404 billion in Q1 2026, $7.660 billion in Q4 2025, $7.844 billion in Q3 2025, and $7.611 billion now. The sequential pattern shows revenue peaking in Q3 2025 and drifting lower, consistent with a bank whose net interest income is being pressured by deposit costs and modest loan growth. Segment disclosure is thin (Community Banking $43 million, Financial Services $9 million, Other/Treasury -$52 million), but the consolidated picture implies the core banking franchise is not yet delivering the revenue acceleration that would justify a re-rating.
Profitability is solid and improving: Q2 2026 net income was $1.553 billion with a 20.4% net margin, up from $1.240 billion and a 16.4% margin in Q2 2025, and gross margin expanded to 63.99% from 59.56% a year earlier. Operating margin of 23.85% in Q2 2026 versus 20.03% in Q2 2025 shows meaningful operating leverage, and the trailing net margin of 17.44% with a 62.21% gross margin is respectable for a regional bank. The trajectory — four consecutive quarters of net income above $1.35 billion and rising EPS ($1.24 diluted in Q2 2026 versus $0.90 a year ago) — suggests the profitability story is intact even as the top line stalls.
Balance-sheet and cash-flow metrics are adequate but not exceptional: debt-to-equity is 1.07, ROE is 8.14%, ROA is just 1.06%, and the current ratio of 0.866 reflects the bank's liability-heavy structure rather than a liquidity problem. Free cash flow TTM is $5.797 billion, but quarterly operating cash flow is lumpy ($1.039 billion in Q2 2026, $679 million in Q1 2026, $2.582 billion in Q4 2025), and the bank returned capital aggressively — $670 million of dividends and $1.2 billion of buybacks in Q2 2026 alone. The 4.80% dividend yield with a 56.45% payout ratio is well covered, and the $39.3 billion cash position provides ample liquidity, but the low ROE and thin ROA mean Truist depends on capital returns and margin improvement rather than organic profitability to drive shareholder value.
Quarterly Revenue
$7.6B
2026-06
Revenue YoY Growth
+0.8%
YoY Comparison
Gross Margin
64.0%
Latest Quarter
Free Cash Flow
$5.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is TFC Overvalued?
Because net income is positive ($1.553 billion in Q2 2026), the PE ratio is the appropriate primary metric: Truist trades at 12.75x trailing earnings and just 9.48x forward earnings, a 25.6% discount that implies the market expects meaningful EPS growth — consistent with consensus 2027 EPS of $5.59 versus the current run-rate. The PEG ratio of 0.857 (below 1.0) suggests the stock is cheap relative to its expected growth, while the 0.957 price-to-book ratio means investors are paying less than book value for the franchise.
Against regional-bank peers, Truist screens as a discount name: a 0.96x P/B versus the sector typically trading at or above book, a 12.75x trailing PE that is modest for a $62 billion market-cap bank, and a 2.05x P/S that is low in absolute terms. The 4.80% dividend yield is well above the sector average and the 9.48x forward PE implies the market is pricing in credit concerns or margin compression that the company's 20.4% net margin and 23.85% operating margin do not currently support. The discount appears at least partly justified by the flat revenue trajectory and below-peer ROE of 8.14%, but the gap between price and book value leaves limited downside if fundamentals merely hold steady.
Historically, Truist's PE has ranged from roughly 8.0x (Q1 2023) to 15.8x (Q2 2024), and its P/B has ranged from about 0.62x (Q3 2023) to 1.16x (Q1 2022); at 12.75x PE and 0.96x P/B, the stock sits in the middle-to-lower portion of its own band. The P/B of 0.96x is above the 0.83–0.90x levels seen through 2023–2025, suggesting the market has already re-rated the book modestly, while the PE of 12.75x is above the 2023 trough but below the 2024 peak. The current valuation therefore prices in neither euphoria nor distress — it reflects a bank that has stabilized but not yet proven it can grow.
PE
12.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 8x~14x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on Truist's ability to grow revenue in a flat net interest income environment. Q2 2026 revenue rose only 0.75% year over year, and the sequential trend shows revenue declining from $7.844 billion in Q3 2025 to $7.611 billion now. With a debt-to-equity ratio of 1.07 and a current ratio of 0.866, the bank carries typical leverage for a regional bank but has limited flexibility if credit costs rise. ROE of 8.14% and ROA of 1.06% are below peer averages, meaning the bank depends on capital returns and margin improvement rather than organic profitability to create value. Additionally, the $1.2 billion quarterly buyback and $670 million dividend consume a significant portion of earnings, leaving less room for error if earnings decline.
Market and competitive risks include valuation compression if the stock fails to meet growth expectations. TFC trades at 0.96x book and 9.48x forward earnings, which is already a discount, but if revenue remains flat, the discount could widen toward the 2023 trough of 0.62x book. The stock's beta of 0.906 offers only modest downside cushion, and its negative relative strength (-17.30% YTD vs. SPY) indicates persistent underperformance that could trigger further selling. Recent analyst downgrades to Neutral/Equal Weight and Underweight reflect concerns about margin compression and credit normalization. Competition from larger money-center banks and fintechs could pressure loan growth and deposit costs.
Worst-case scenario: a recession-driven credit deterioration combined with margin compression could push the stock toward its 52-week low of $41.60, representing an 11.6% decline from $47.07. If analysts cut targets to the low end of $45.00, that implies a 4.4% downside, but a more severe scenario could see the stock test the 2023 P/B trough of 0.62x, implying a price near $30 (based on book value per share of roughly $49). However, the 52-week low of $41.60 is a more immediate reference, and a break below $46 could accelerate selling toward that level. Investors could lose 11.6% to 35% in a severe downturn.
FAQ
The most severe risk is credit deterioration, particularly in commercial real estate, which could force higher provisions and erode profitability. Second, revenue stagnation (0.75% YoY growth) could persist, leading to further analyst downgrades and multiple compression. Third, the stock's negative relative strength and 3.93 short ratio indicate persistent selling pressure that could drive shares toward the 52-week low of $41.60. Fourth, regulatory changes or a recession could impact capital return plans, reducing the buyback and dividend support. Each risk is quantifiable: a 1% increase in provisions could reduce EPS by roughly 10%, while a break below $46 could trigger a 11.6% decline to the low.
Our 12-month forecast has a base case (55% probability) of $50–$54, assuming flat revenue and stable margins, with the stock gravitating toward the analyst average target of $54.03. The bull case (25% probability) targets $56.20–$61.00 if net interest margin expands and loan growth accelerates, while the bear case (20% probability) sees $41.60–$45.00 if credit costs rise or revenue declines. The most likely scenario is the base case, as it aligns with consensus EPS of $5.59 and the current valuation. Key to the forecast is whether Truist can break out of its revenue rut; without growth, the stock may remain range-bound.
TFC appears undervalued on traditional metrics: it trades at 0.96x book value, 9.48x forward earnings, and a PEG ratio of 0.857, all below sector averages and historical norms. The 4.8% dividend yield is well above the market average. However, the discount is partly justified by a low ROE of 8.14% and flat revenue growth of 0.75%. The market is pricing in continued margin pressure and credit concerns, but if those fears prove overblown, the stock could re-rate toward book value or higher. Relative to its own history, the P/B of 0.96x is above the 2023 trough of 0.62x but below the 2022 peak of 1.16x, suggesting a fair to slightly cheap valuation.
TFC is a reasonable buy for income-oriented investors seeking a 4.8% dividend yield and exposure to a cheap regional bank trading below book value (0.96x P/B). The stock offers 14.8% upside to the average analyst target of $54.03, but near-term momentum is negative, with shares down 10.34% over three months and underperforming the S&P 500 by 17.30% YTD. The biggest downside risk is a test of the 52-week low of $41.60, about 11.6% below the current price. For value investors with a long horizon, the risk/reward is favorable, but those seeking quick gains may find better opportunities elsewhere.
TFC is better suited for long-term investment, given its 4.8% dividend yield, below-book valuation, and beta of 0.906, which offers lower volatility than the market. Short-term trading is less attractive due to the stock's negative momentum (-10.34% over three months) and lack of near-term catalysts. The dividend and buyback program provide a total return framework that rewards patience. We suggest a minimum holding period of 12–18 months to allow for potential margin improvement and revenue stabilization. However, investors should monitor the $46 support level; a break below could warrant a reassessment.